机译:新生和继发性间变性脑膜瘤:临床和组织分子预后因素的研究
Grp Hosp Pitie Salpetriere, AP HP, Dept Neurosurg, Paris, France;
CHRU, U954, INSERM, Dept Pathol, Nancy, France;
Inst Cerveau & Moelle Epiniere, INSERM, Unit 1127, Paris, France;
Hop Lariboisiere, AP HP, Dept Neurosurg, Paris, France;
Hop St Anne, Dept Neurosurg, Paris, France;
Hop La Timone, Dept Neurosurg, Marseille, France;
Hop La Pitie Salpetriere, AP HP, Dept Neuropathol, Paris, France;
Hop Beaujon, Dept Neuropathol, Clichy, France;
Paris Descartes Univ, Sorbonne Paris Cite, Paris, France;
Aix Marseille Univ, La Timone Hosp, AP HM, Dept Pathol & Neuropathol,CRO2, Marseille, France;
Hop Pellegrin, Dept Neurosurg, Bordeaux, France;
Grp Hosp Pitie Salpetriere, AP HP, Dept Neurosurg, Paris, France;
anaplastic; grade 3; meningioma; prognosis; TERT;
机译:从头和进展性非典型和间变性脑膜瘤中EGFR表达的预后价值:免疫组化和荧光原位杂交初步研究
机译:从头和继发性间变性脑膜瘤:自然病史,预后和TERT启动子
机译:具有局部诊断的间变性少突胶质细胞瘤或少星形胶质细胞瘤的患者的新型临床,病理和分子预后模型和计算器。欧洲癌症脑肿瘤研究与治疗组织26951的预后因素分析
机译:弥漫性轴索损伤的昏迷持续时间预测:表观扩散系数和临床预后因素的分析。
机译:了解JunB转录因子在间变性淋巴瘤激酶阳性,间变性大细胞淋巴瘤中的功能。
机译:新生和继发性间变性脑膜瘤:临床和组织分子预后因素的研究
机译:脑胶质瘤的内在分子亚型可预后并预测佐普卡巴嗪,洛莫斯汀和长春新碱化学疗法与间变性少突神经胶质脑肿瘤的其他预后因素相结合的优势:EORTC研究26951的报告